Get the Stockscreener App
357.05
1.48%
-5.37
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $357.05, with a volume of 606.65K.
It is down -1.48% in the last 24 hours and down -2.55% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$362.42
Open:
$361.7
24h Volume:
606.65K
Relative Volume:
0.34
Market Cap:
$136.55B
Revenue:
$25.12B
Net Income/Loss:
$3.25B
P/E Ratio:
42.50
EPS:
8.4018
Net Cash Flow:
$4.28B
1W Performance:
-3.38%
1M Performance:
-2.55%
6M Performance:
-4.77%
1Y Performance:
-9.85%
1-Day Range:
$356.65
$364.81
1-Week Range:
$356.65
$371.90
52-Week Range:
$329.16
$404.14
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
357.07 | 138.60B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
ABT
Abbott Laboratories
|
109.53 | 189.68B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
MDT
Medtronic Plc
|
102.53 | 131.98B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
76.19 | 115.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.19 | 45.32B | 5.88B | 1.34B | 799.60M | 2.3489 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Orthopedic Implants Market Size to Reach USD 33.20 Billion by 2033, Driven by Rising Musculoskeletal Disorders and Surgical Innovation – SNS Insider - GlobeNewswire Inc.
J.W. Cole Advisors Inc. Trims Stock Position in Stryker Corporation $SYK - MarketBeat
Stryker Dividend Hike Highlights Shareholder Returns And Valuation Trade Offs - simplywall.st
Witnessing An Insider Decision, Spencer S Stiles Exercises Options Valued At $3.70M At Stryker - Benzinga
Stryker tops $25B in revenue and signals confidence in 2026 growth - Crain's Grand Rapids
Stryker declares quarterly dividend of $0.88 per share - Investing.com
Stryker declares an $0.88 per share quarterly dividend - Yahoo Finance UK
Jones Financial Companies Lllp Boosts Stake in Stryker Corporation $SYK - MarketBeat
Stryker group president Pierce sells $175k in shares By Investing.com - Investing.com South Africa
Stryker group president Pierce sells $175k in shares - Investing.com
10 Best Health Care Stocks to Buy for 2026 - US News Money
Stryker Corporation $SYK Shares Sold by Mediolanum International Funds Ltd - MarketBeat
Morgan Stanley Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $445 - 富途牛牛
Stryker Corporation (NYSE:SYK) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Atle Fund Management AB Has $8.42 Million Stake in Stryker Corporation $SYK - MarketBeat
Stryker (SYK) Earnings Call Highlights Growth and Resilience - TipRanks
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $387 to $465 - 富途牛牛
Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Regeneron (REGN) and NewAmsterdam Pharma Company (NAMS) - The Globe and Mail
Stryker Corporation (NYSE:SYK) Q4 2025 Earnings Call Transcript - Insider Monkey
Stryker raises annual profit forecast on strong sales for medical devices - Reuters
Assessing Stryker (SYK) Valuation After Strong Results And Optimistic 2026 Growth Outlook - Yahoo Finance
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $412 to $454 - 富途牛牛
Piper Sandler Maintains Overweight Rating on Stryker Corporation (SYK) - Finviz
Stryker starts first cases with handheld ortho robot - MedTech Dive
Stryker (NYSE:SYK) Shares Gap Up Following Better-Than-Expected Earnings - MarketBeat
Stryker stock price target raised to $412 from $410 at BTIG By Investing.com - Investing.com South Africa
Evercore ISI Adjusts Stryker Price Target to $400 From $390, Maintains Outperform Rating - marketscreener.com
BTIG Research Adjusts Stryker Price Target to $412 From $410, Maintains Buy Rating - marketscreener.com
Needham raises Stryker stock price target to $454 on strong Q4 results By Investing.com - Investing.com South Africa
Barclays Adjusts Stryker Price Target to $469 From $462, Maintains Overweight Rating - marketscreener.com
Stryker (NYSE:SYK) Given New $454.00 Price Target at Needham & Company LLC - MarketBeat
Needham raises Stryker stock price target to $454 on strong Q4 results - Investing.com
Canaccord Genuity reiterates Buy rating on Stryker stock with $435 target By Investing.com - Investing.com India
Stryker (NYSE:SYK) Issues FY 2026 Earnings Guidance - MarketBeat
Canaccord Genuity reiterates Buy rating on Stryker stock with $435 target - Investing.com
Stryker rises after raising annual profit forecast - TradingView
Stryker enters 2026 with ‘strong momentum’ after FY25 revenue eclipses $25bn - Yahoo Finance
Knights of Columbus Asset Advisors LLC Has $8.95 Million Holdings in Stryker Corporation $SYK - MarketBeat
Stryker price target raised to $412 from $410 at BTIG - TipRanks
Pittenger & Anderson Inc. Acquires 11,827 Shares of Stryker Corporation $SYK - MarketBeat
Tandem Investment Advisors Inc. Acquires 7,425 Shares of Stryker Corporation $SYK - MarketBeat
The Analyst Verdict: Stryker In The Eyes Of 11 Experts - Benzinga
Stryker stock rating reiterated at Market Outperform by Citizens - Investing.com
Stryker (SYK) Receives Price Target Increase from Needham | SYK Stock News - GuruFocus
Stryker Corporation $SYK Shares Bought by Mirae Asset Global Investments Co. Ltd. - MarketBeat
BTIG Raises Price Target for Stryker (SYK) to $412 Following Ana - GuruFocus
Stryker stock price target raised to $412 from $410 at BTIG - Investing.com
Benedict Financial Advisors Inc. Makes New Investment in Stryker Corporation $SYK - MarketBeat
Federated Hermes Inc. Grows Position in Stryker Corporation $SYK - MarketBeat
Stryker Q4 Earnings Call Highlights - Yahoo Finance
Stryker’s 2025 Q4 earnings exceed Wall Street predictions - MassDevice
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):